What if someone recommends off-label uses for a drug on the Facebook page of a pharmaceutical company? Or how about if someone makes unsubstantiated claims about an investment product on the Facebook page of a financial firm. Increasingly, companies are concerned that their Facebook pages could expose them to compliance risks. In fact, until recently, […]
